Related Experiment Videos
Efficacy of over-the-counter nicotine patch.
Saul Shiffman1, Jane Gorsline, Charles W Gorodetzky
1Pinney Associates and University of Pittsburgh, Pennsylvania 15213, USA. shiffman@pinneyassociates.com
Summary
The nicotine patch significantly increases smoking cessation success rates compared to placebo. This study demonstrates its effectiveness even without direct counseling, supporting over-the-counter accessibility.
Area of Science:
- Pharmacology
- Public Health
- Addiction Medicine
Background:
- Smoking cessation remains a significant public health challenge.
- Nicotine replacement therapy (NRT) is a widely used intervention.
- Assessing NRT efficacy under real-world, over-the-counter conditions is crucial.
Purpose of the Study:
- To evaluate the efficacy of the nicotine patch for smoking cessation.
- To simulate over-the-counter (OTC) sales conditions without direct behavioral support.
- To determine the safety and effectiveness of the nicotine patch in a simplified treatment protocol.
Main Methods:
- A randomized, double-blind, placebo-controlled, multicenter trial involving 567 smokers.
- Participants received either an active nicotine patch or a placebo patch.
- A stepped-dosing regimen (21 mg, 14 mg, 7 mg) over 10 weeks with minimal instructions.
Main Results:
- Active nicotine patch use resulted in significantly higher continuous abstinence rates at 6 weeks (19.4% vs. 7.0%) and 10 weeks (15.2% vs. 5.3%).
- Seven-day point-prevalence abstinence rates were also significantly higher for the active patch at 6 weeks (26.1% vs. 7.7%) and 10 weeks (23.3% vs. 7.7%).
- Adverse events were mild and consistent with known nicotine patch side effects, indicating a favorable safety profile.
Conclusions:
- The nicotine patch is a safe and effective tool for smoking cessation.
- Its efficacy is demonstrated even when provided without intensive behavioral counseling or face-to-face support.
- Findings support the use of nicotine patches under simulated over-the-counter conditions.